These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
590 related articles for article (PubMed ID: 18357366)
1. Clinicopathological significance of the fragile histidine triad transcription protein expression in laryngeal carcinogenesis. Kitamura K; Hayashi K; Kobayashi R; Ishii H; Matsubayashi J; Matsumoto T; Suzuki M Oncol Rep; 2008 Apr; 19(4):847-52. PubMed ID: 18357366 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma. Yang Q; Yoshimura G; Suzuma T; Tamaki T; Umemura T; Nakamura M; Nakamura Y; Wang X; Mori I; Sakurai T; Kakudo K Clin Cancer Res; 2001 Dec; 7(12):3869-73. PubMed ID: 11751477 [TBL] [Abstract][Full Text] [Related]
3. [Correlation of FHIT expression to cell proliferation and metastasis of laryngeal squamous cell carcinoma]. Yin DT; Lu XB; Dong MM; Qiu XG; Wang QZ Ai Zheng; 2004 Nov; 23(11):1338-41. PubMed ID: 15522186 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance of fragile histidine triad transcription protein expression in endometrial carcinomas. Segawa T; Sasagawa T; Saijoh K; Inoue M Clin Cancer Res; 2000 Jun; 6(6):2341-8. PubMed ID: 10873085 [TBL] [Abstract][Full Text] [Related]
5. Altered p16INK4a and Fhit expression in carcinogenesis and progression of human oral cancer. Paradiso A; Ranieri G; Stea B; Zito A; Zehbe I; Tommasino M; Grammatica L; De Lena M Int J Oncol; 2004 Feb; 24(2):249-55. PubMed ID: 14719099 [TBL] [Abstract][Full Text] [Related]
6. The fragile histidine triad gene: a molecular link between cigarette smoking and cervical cancer. Holschneider CH; Baldwin RL; Tumber K; Aoyama C; Karlan BY Clin Cancer Res; 2005 Aug; 11(16):5756-63. PubMed ID: 16115913 [TBL] [Abstract][Full Text] [Related]
7. Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival. Capuzzi D; Santoro E; Hauck WW; Kovatich AJ; Rosato FE; Baffa R; Huebner K; McCue PA Cancer; 2000 Jan; 88(1):24-34. PubMed ID: 10618602 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of fragile histidine triad expression in tumors from saudi arabia: a tissue microarray analysis. Bavi P; Jehan Z; Atizado V; Al-Dossari H; Al-Dayel F; Tulbah A; Amr SS; Sheikh SS; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1708-18. PubMed ID: 16985034 [TBL] [Abstract][Full Text] [Related]
10. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance. Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757 [TBL] [Abstract][Full Text] [Related]
11. [Abnormal expression of fragile histidine triad (FHIT) and Mut S homolog 2 (MSH2) proteins in human sporadic colorectal carcinoma and their clinical significance]. Yao CC; Lin CY; Hu MB Ai Zheng; 2004 Mar; 23(3):310-6. PubMed ID: 15025965 [TBL] [Abstract][Full Text] [Related]
12. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Sozzi G; Pastorino U; Moiraghi L; Tagliabue E; Pezzella F; Ghirelli C; Tornielli S; Sard L; Huebner K; Pierotti MA; Croce CM; Pilotti S Cancer Res; 1998 Nov; 58(22):5032-7. PubMed ID: 9823304 [TBL] [Abstract][Full Text] [Related]
13. Prognostic relevance of fragile histidine triad protein expression in patients with small cell lung cancer. Rohr UP; Rehfeld N; Geddert H; Pflugfelder L; Bruns I; Neukirch J; Rohrbeck A; Grote HJ; Steidl U; Fenk R; Opalka B; Gabbert HE; Kronenwett R; Haas R Clin Cancer Res; 2005 Jan; 11(1):180-5. PubMed ID: 15671544 [TBL] [Abstract][Full Text] [Related]
14. Loss of FHIT expression in breast cancer is correlated with poor prognostic markers. Arun B; Kilic G; Yen C; Foster B; Yardley DA; Gaynor R; Ashfaq R Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1681-5. PubMed ID: 16030101 [TBL] [Abstract][Full Text] [Related]
15. Loss of Fhit expression is a predictor of poor outcome in tongue cancer. Lee JI; Soria JC; Hassan K; Liu D; Tang X; El-Naggar A; Hong WK; Mao L Cancer Res; 2001 Feb; 61(3):837-41. PubMed ID: 11221865 [TBL] [Abstract][Full Text] [Related]
16. Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions. Pavelić K; Dedivitis RA; Kapitanović S; Cacev T; Guirado CR; Danić D; Radosević S; Brkić K; Pegan B; Krizanac S; Kusić Z; Spaventi S; Bura M Mutat Res; 2006 Jul; 599(1-2):45-57. PubMed ID: 16698048 [TBL] [Abstract][Full Text] [Related]
17. Reduced acetylated histone H4 is associated with promoter methylation of the fragile histidine triad gene in resected esophageal squamous cell carcinoma. Tzao C; Sun GH; Tung HJ; Hsu HS; Hsu WH; Wang YC; Cheng YL; Lee SC Ann Thorac Surg; 2006 Aug; 82(2):396-401; discussion 401. PubMed ID: 16863736 [TBL] [Abstract][Full Text] [Related]
18. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma. Segawa T; Sasagawa T; Yamazaki H; Sakaike J; Ishikawa H; Inoue M Cancer; 1999 May; 85(9):2001-10. PubMed ID: 10223242 [TBL] [Abstract][Full Text] [Related]
19. Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma. Zhao P; Lu Y; Zhong M; Liu L; Li B Acta Oncol; 2008; 47(8):1557-63. PubMed ID: 18618300 [TBL] [Abstract][Full Text] [Related]
20. Analysis of FHIT allelic imbalance/loss of heterozygosity and FHIT expression in cutaneous squamous cell carcinomas. Gray SE; Kay E; Leader M; Mabruk M J Cutan Pathol; 2008 Sep; 35(9):816-25. PubMed ID: 18494825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]